Arkolith/Insider Trading/SMMT/Form 4

Duggan Robert W

Co-Chief Executive Officer, Director, 10% OwnerSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Oct 23, 2025
Net Buying
Open-Market Buys
$500K
Open-Market Sells
$0
Net Open-Market Flow
$500K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 21, 2025Grant(A)267K$18.74$5.0M25.7M
Oct 21, 2025Buy(P)27K$18.74$500K77K
Oct 21, 2025Grant(A)14.0M$18.74$262.0M570.1M

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001055919-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML